Drug intelligence / Profile preview

Bufei Yishen Granules

Development stage
Unknown
Lead developer
Henan University of Chinese Medicine
Administration
Oral
01

Overview

Bufei Yishen Granules (补肺益肾颗粒) is a traditional Chinese medicine (TCM) herbal formulation designed to "tonify the lungs and benefit the kidneys." It is composed of multiple herbs including Astragalus membranaceus (Huang Qi), Cornus officinalis (Shan Zhu Yu), Lycium barbarum (Gou Qi Zi), Schisandra chinensis (Wu Wei Zi), Fritillaria thunbergii (Zhe Bei Mu), Perilla frutescens seed (Zi Su Zi), Citrus reticulata peel (Chen Pi), Paeonia lactiflora root (Bai Shao), Epimedium brevicornum Maxim. (Yin Yang Huo), Stemona japonica or Cynanchum stauntonii root/tuber ("Zi Jin Niu" or Bai Bu), Lumbricus ("Di Long"), and Panax ginseng root ("Ren Shen")[1]. The granule form is produced via water extraction from these herbs. The primary clinical indication for Bufei Yishen Granules is chronic obstructive pulmonary disease (COPD). Clinical studies have shown that it can improve quality of life and reduce inflammation in patients with stable COPD[2][4]. Mechanistic research suggests that its effects are mediated by modulation of autophagy pathways—specifically upregulation of Sirt1/AMPK/FOXO3 signaling, increased expression of autophagy-related proteins such as LC3-B and Beclin-1, reduction in inflammatory cytokines like TNF-α, IL-8, IL-1β, and inhibition of apoptosis markers such as Bax and Caspase-3[3]. These actions contribute to improved airway epithelial barrier function and reduced lung inflammation.

Brand names
Bufei Yishen GranulesBu Fei Yi Shen Keli补肺益肾颗粒
Other names
Bu Fei Yi Shen GranulesBFYSG
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)FOXO3 (Forkhead box protein O3)IL1B (Interleukin-1 beta)IL8 (C-X-C Motif Chemokine Ligand 8)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Bufei Yishen Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bufei Yishen Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call